Supplementary Data S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Supplementary Data S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

<p>Raw RNAseq data corresponding to Figures 2C, 4D and Supplemental Figure 2B</p>

保存先:

書誌詳細
第一著者:	Christopher T. Letson (16424095) (author)
その他の著者:	Maria E. Balasis (15033630) (author), Hannah Newman (15033618) (author), Moritz Binder (16424098) (author), Alexis Vedder (16424101) (author), Fumi Kinose (16424104) (author), Markus Ball (15033633) (author), Traci Kruer (15134201) (author), Ariel Quintana (16424107) (author), Terra L. Lasho (16424110) (author), Christy M. Finke (16424113) (author), Luciana L. Almada (16424116) (author), Jennifer M. Grants (16424119) (author), Guolin Zhang (15098544) (author), Martin E. Fernandez-Zapico (16424122) (author), Alexandre Gaspar-Maia (16424125) (author), Jeffrey Lancet (16424128) (author), Rami Komrokji (16424131) (author), Eric Haura (16424134) (author), David A. Sallman (15134216) (author), Gary W. Reuther (16424137) (author), Aly Karsan (15024852) (author), Uwe Rix (15040221) (author), Mrinal M. Patnaik (16424140) (author), Eric Padron (15134222) (author)
出版事項:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling Growth factors Gene Regulation Posttranscriptional and translational control Hematological Cancers Leukemias Translational Research
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

類似資料

Supplementary Data S1 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
著者:: Christopher T. Letson (16424095)
出版事項: (2025)

Supplementary Table S1 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
著者:: Christopher T. Letson (16424095)
出版事項: (2025)

Supplementary Table S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
著者:: Christopher T. Letson (16424095)
出版事項: (2025)

Supplementary Table S3 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
著者:: Christopher T. Letson (16424095)
出版事項: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
著者:: Jonathan M.J. Derry (16648337)
出版事項: (2025)

Table S1 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
著者:: Yun-Guang Hong (14960966)
出版事項: (2025)

Table S2 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
著者:: Yun-Guang Hong (14960966)
出版事項: (2025)

Table S3 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
著者:: Yun-Guang Hong (14960966)
出版事項: (2025)

Table S4 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
著者:: Yun-Guang Hong (14960966)
出版事項: (2025)

Table S5 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
著者:: Yun-Guang Hong (14960966)
出版事項: (2025)

Table S6 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
著者:: Yun-Guang Hong (14960966)
出版事項: (2025)

Figure 1 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Figure 2 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Figure 3 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Figure 4 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Figure 5 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Figure 6 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Figure 7 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
著者:: Meng Li (79487)
出版事項: (2025)

Supplementary Table S3 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
著者:: Shima Nakanishi (16336496)
出版事項: (2025)

Supplementary Table S4 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
著者:: Shima Nakanishi (16336496)
出版事項: (2025)

Supplementary Tables S1-5 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL
著者:: Yiming Wu (15306005)
出版事項: (2025)

Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
著者:: Xun-Xi Lu (14952883)
出版事項: (2025)

Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
著者:: Xun-Xi Lu (14952883)
出版事項: (2025)

Table S3 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
著者:: Xun-Xi Lu (14952883)
出版事項: (2025)

Table S7 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
著者:: Xun-Xi Lu (14952883)
出版事項: (2025)

Table S8 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
著者:: Xun-Xi Lu (14952883)
出版事項: (2025)

Supplementary Table 1 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
著者:: Duygu Kuzuoglu-Ozturk (14960213)
出版事項: (2025)

Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
著者:: Duygu Kuzuoglu-Ozturk (14960213)
出版事項: (2025)

Supplementary Table 3 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
著者:: Duygu Kuzuoglu-Ozturk (14960213)
出版事項: (2025)

Table S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
著者:: Cheng-Kai Wang (14963880)
出版事項: (2025)

Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
著者:: Yufang Bao (15386826)
出版事項: (2025)

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
著者:: Yufang Bao (15386826)
出版事項: (2025)

Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
著者:: Yufang Bao (15386826)
出版事項: (2025)

Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
著者:: Yufang Bao (15386826)
出版事項: (2025)

Cannot write session to /tmp/vufind_sessions/sess_t49k5hm88k18nl9onue8mv8u5v